FAIRFIELD, NJ / ACCESS Newswire / January 30, 2026 / Jerash Holdings (US), Inc. (NASDAQ:JRSH) (the “Company” or “Jerash”), which manufactures and exports custom, ready-made sportswear and outerwear for leading global brands, today announced it will release its financial results for fiscal 2026 third quarter ended December 31, 2025, before the market opens on Monday, February 9, 2026. The Company will host an investor conference call the same day.
Call Date: Monday, February 9, 2026
Time: 9:00 a.m. ET
Phone: 888-506-0062 (domestic); 973-528-0011 (international)
Conference ID: 422515
A live and archived webcast will be available online in the investor relations section of Jerash’s website at www.jerashholdings.com. For those who are not able to listen to the live broadcast, the call will be archived for approximately one year on the website.
About Jerash Holdings (US), Inc.
Jerash Holdings (US), Inc. manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands and retailers, including VF Corporation (which owns brands such as The North Face, Timberland, and Vans), New Balance, G-III (which licenses brands such as DKNY and Nautica), Acushnet Holdings Corp (which owns the brand FootJoy), American Eagle, and Skechers. Jerash’s existing production facilities in Jordan comprise six factory units and four warehouses, and Jerash currently employs approximately 6,000 people. Additional information is available at www.jerashholdings.com.
# # #
Contact:
PondelWilkinson Inc.
Judy Lin or Roger Pondel
310-279-5980
jlin@pondel.com
SOURCE: Jerash Holdings (US), Inc.
View the original press release on ACCESS Newswire
LAS VEGAS, JUNE 8, 2026 — tvONE, an ACT Entertainment brand, debuts its most powerful…
MAIDENHEAD, UK — tvONE and Green Hippo today announced that Pixel Academy will host two…
ACT Entertainment, one of the world's preeminent manufacturers and distributors of audio, video, and lighting…
Veteran Technology Leader Will Advance Responsible AI Innovation Across Accurate's Global Screening Platform, Products and…
No approved drug, clinical-stage asset, or competing research program targets the mechanisms that Liquid's Emerge…
This integration brings LED Lighting Supply's full product catalog directly into the STACK platform, the…